摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-methyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | 117607-12-2

中文名称
——
中文别名
——
英文名称
(R)-2-methyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
英文别名
benzyl (S)-2-methylpyrrolidine-1-carboxylate;benzyl 2-methylpyrrolidine-1-carboxylate;(R)-2-Methyl-1-pyrrolidinecarboxylic acid benzyl ester;benzyl (2R)-2-methylpyrrolidine-1-carboxylate
(R)-2-methyl-1-pyrrolidinecarboxylic acid phenylmethyl ester化学式
CAS
117607-12-2
化学式
C13H17NO2
mdl
——
分子量
219.283
InChiKey
QRXDMGQDNTUTTO-LLVKDONJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.107

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (R)-2-methyl-1-pyrrolidinecarboxylic acid phenylmethyl ester氢溴酸溶剂黄146 作用下, 以96%的产率得到(R)-2-methylpyrrolidine hydrobromide
    参考文献:
    名称:
    A new class of potent non-imidazole H3 antagonists: 2-aminoethylbenzofurans
    摘要:
    2-Aminoethylbenzofurans constitute a new class of H-3 antagonists that are more rotationally constrained than most previously reported H-3 antagonists. They retain high potency at human and rat receptors, with efficient CNS penetration observed in 35. The SAR of the basic amine moiety was compared in three different series of analogues. The greatest potency was found in analogues bearing a 2-methylpyrrolidine, a 2,5-dimethylpyrrolidine, or a 2,6-dimethylpiperidine. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.11.032
  • 作为产物:
    描述:
    (S)-1-n-cbz-2-氯甲基吡咯烷偶氮二异丁腈三正丁基氢锡 作用下, 以 甲苯 为溶剂, 以85%的产率得到(R)-2-methyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
    参考文献:
    名称:
    A new class of potent non-imidazole H3 antagonists: 2-aminoethylbenzofurans
    摘要:
    2-Aminoethylbenzofurans constitute a new class of H-3 antagonists that are more rotationally constrained than most previously reported H-3 antagonists. They retain high potency at human and rat receptors, with efficient CNS penetration observed in 35. The SAR of the basic amine moiety was compared in three different series of analogues. The greatest potency was found in analogues bearing a 2-methylpyrrolidine, a 2,5-dimethylpyrrolidine, or a 2,6-dimethylpiperidine. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.11.032
点击查看最新优质反应信息

文献信息

  • Catalytic Reduction of Alkyl and Aryl Bromides Using Propan-2-ol
    作者:Michael C. Haibach、Brian M. Stoltz、Robert H. Grubbs
    DOI:10.1002/anie.201708800
    日期:2017.11.20
    complex: Milstein's complex, (PNN)RuHCl(CO), catalyzes the efficient reduction of alkyl bromides and chlorides under relatively mild reaction conditions by using propan-2-ol and a base. Sterically hindered tertiary and neopentyl substrates are reduced efficiently, as well as more-functionalized aryl and alkyl bromides. The reaction appears to occur by a radical pathway, and provides an alternative to
    一个简单的配合物:米尔斯坦配合物(PNN)RuHCl(CO),通过使用丙-2-醇和一种碱,在相对温和的反应条件下催化有效还原烷基化物和化物。受阻位的叔和新戊基底物以及功能更强的芳基和烷基化物均能有效还原。该反应似乎是通过自由基途径发生的,它提供了硅烷,氢化铝和基还原的替代方法。
  • Processes for Producing Optically Active 1-Substituted 2-Methylpyrrolidine and Intermediate Therefor
    申请人:Nishiyama Akira
    公开号:US20070292926A1
    公开(公告)日:2007-12-20
    The present invention relates to a process for producing an optically active 1,4-pentanediol by asymmetrically reducing 5-hydroxy-2-pentanone, which is easily available at low cost. The present invention also relates to a process for producing an optically active 1-substituted 2-methylpyrrolidine including sulfonylating the optically active 1,4-pentanediol to convert it to an optically active sulfonate compound, and reacting the compound with an amine. According to the processes of the present invention, an optically active 1,4-pentanediol and an optically active 1-substituted 2-methylpyrrolidine, which are useful as an intermediate for medicines and an intermediate for agricultural chemicals, can be simply produced from an inexpensive starting material.
    本发明涉及一种生产光学活性1,4-戊二醇的过程,该过程通过非对称还原低成本易得的5-羟基-2-戊酮。本发明还涉及一种生产光学活性1-取代-2-甲基吡咯烷的过程,包括将光学活性1,4-戊二醇磺酰化以转化为光学活性磺酸盐化合物,并将该化合物与胺反应。根据本发明的工艺,可以从廉价的起始材料简单地生产出作为药物中间体和农药中间体的光学活性1,4-戊二醇和光学活性1-取代-2-甲基吡咯烷
  • Acylative kinetic resolution of racemic methyl-substituted cyclic alkylamines with 2,5-dioxopyrrolidin-1-yl (<i>R</i>)-2-phenoxypropanoate
    作者:Dmitry A. Gruzdev、Sergey A. Vakarov、Marina A. Korolyova、Ekaterina V. Bartashevich、Andrey A. Tumashov、Evgeny N. Chulakov、Marina A. Ezhikova、Mikhail I. Kodess、Galina L. Levit、Victor P. Krasnov
    DOI:10.1039/d1ob02099d
    日期:——
    methyl-substituted cyclic alkylamines with active esters of 2-phenoxypropanoic acid was studied in detail. The ester of (R)-2-phenoxypropanoic acid and N-hydroxysuccinimide was found to be the most selective agent. The highest stereoselectivity was observed in the kinetic resolution of racemic 2-methylpiperidine in toluene at −40 °C (selectivity factor s = 73) with the predominant formation of (R,R)-amide
    详细研究了一些外消旋甲基取代的环状烷基胺与2-苯氧基丙酸的活性酯的非对映选择性酰化反应。( R )-2-苯氧基丙酸和N-羟基琥珀酰亚胺的酯被发现是最具选择性的试剂。在 -40 °C 下,在甲苯中的外消旋 2-甲基哌啶的动力学拆分中观察到最高的立体选择性(选择性因子s = 73),主要形成 ( R , R )-酰胺 (93.7% de)。为了解释观察到的立体选择性,对标题酰化剂与 2-甲基哌啶2-甲基吡咯烷反应中的过渡态进行了 DFT 建模。计算值与实验数据吻合良好。已经证明酰化通过协同机制进行,其中胺的添加与羟基琥珀酰亚胺片段的消除同时发生。与 ( R , S )-酰胺的形成相比,( R , R )-酰胺形成的高立体选择性很大程度上是由过渡态中较低的空间位阻确保的。
  • Asymmetric Intramolecular Hydroamination of Alkenes in Mild and Wet Conditions-Structure and Reactivity of Cationic Binuclear Gold(I) Catalysts
    作者:Marc-Antoine Abadie、Xavier Trivelli、Florian Medina、Frédéric Capet、Pascal Roussel、Francine Agbossou-Niedercorn、Christophe Michon
    DOI:10.1002/cctc.201402350
    日期:2014.8
    binuclear gold(I) chloride complex was combined with a silver salt to catalyze efficiently, for the first time, the asymmetric intramolecular hydroamination of alkenes with high conversions and enantioselectivities, in mild conditions and in presence of water. Both enantiomers of the products could be obtained by controlling the molecular ion‐pairs through the solvent polarity. The gold(I) cationic
    将所选的二膦双核氯化金(I)络合物与盐混合,以在温和的条件下和在的存在下,首次有效地催化具有高转化率和对映选择性的烯烃的不对称分子内加氢胺化反应。可以通过通过溶剂极性控制分子离子对来获得产物的两种对映异构体。通过X射线分析和溶液中的DOSY 1 H NMR实验,清楚地表征了(I)阳离子活性物质的固态。在催化剂的结合方式上未观察到氯化银的贡献。
  • PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE AMINE DERIVATIVE
    申请人:Nagasawa Toru
    公开号:US20110262977A1
    公开(公告)日:2011-10-27
    Optically active amine derivatives are produced by acting on imine derivatives with a culture of microorganisms having the ability to stereoselectively reduce the compounds, microbial cells, or processed products thereof, followed by collecting the generated optically active amine derivatives. Optically active amine derivatives obtained in the present invention are useful as materials for pharmaceutical agents. The present invention enables, for example, production of an optically active compound represented by formula (IV): (wherein R group represents an alkyl group having one to three carbon atoms; and n represents an integer of 1 to 4).
    光学活性胺衍生物是通过用具有立体选择性还原化合物的微生物培养物作用于亚胺生物,微生物细胞或其加工产品,然后收集生成的光学活性胺衍生物而制备的。本发明所得到的光学活性胺衍生物可用作制药剂的材料。例如,本发明使得可以生产由公式(IV)表示的光学活性化合物:(其中R基表示具有1至3个碳原子的烷基基团;n表示1至4的整数)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫